Compare DYN & HWKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DYN | HWKN |
|---|---|---|
| Founded | 1984 | 1938 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Specialty Chemicals |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.3B |
| IPO Year | 2020 | N/A |
| Metric | DYN | HWKN |
|---|---|---|
| Price | $17.42 | $153.32 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 17 | 2 |
| Target Price | $39.94 | ★ $200.00 |
| AVG Volume (30 Days) | ★ 1.9M | 135.3K |
| Earning Date | 02-26-2026 | 01-28-2026 |
| Dividend Yield | N/A | ★ 0.49% |
| EPS Growth | N/A | ★ 1.59 |
| EPS | N/A | ★ 3.97 |
| Revenue | N/A | ★ $1,045,229,000.00 |
| Revenue This Year | N/A | $14.22 |
| Revenue Next Year | N/A | $7.46 |
| P/E Ratio | ★ N/A | $38.83 |
| Revenue Growth | N/A | ★ 11.86 |
| 52 Week Low | $6.36 | $98.30 |
| 52 Week High | $25.00 | $186.15 |
| Indicator | DYN | HWKN |
|---|---|---|
| Relative Strength Index (RSI) | 44.64 | 59.06 |
| Support Level | $16.00 | $148.09 |
| Resistance Level | $17.50 | $156.17 |
| Average True Range (ATR) | 1.02 | 5.29 |
| MACD | -0.14 | -0.10 |
| Stochastic Oscillator | 38.59 | 63.81 |
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers. The majority of revenue is gained from Water Treatment.